The Re start study due in the June q will sort all of this out.
A good result will see a positive market reaction.
A capital raise will not be undertaken before the release of the Restart Study.
Given resource increases and expected lower costs and higher recoveries a capital raise is not a big issue especially considering that we have a market cap of around $165 mill and a plant alone to build today could be twice that then add the lithium resource and the gold.
It all comes down to how effective the cost reduction and higher recovery programs are.
The better the results the earlier the start.
Management have monitored the programs so they will pretty much know what the Restart study will recommend.
- Forums
- ASX - By Stock
- CXO
- Ann: Finniss Restart Study and Operations Update
CXO
core lithium ltd
Add to My Watchlist
11.2%
!
9.9¢

Ann: Finniss Restart Study and Operations Update, page-68
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.9¢ |
Change
0.010(11.2%) |
Mkt cap ! $212.1M |
Open | High | Low | Value | Volume |
9.0¢ | 10.3¢ | 9.0¢ | $4.168M | 42.64M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 457262 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 145683 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 457262 | 0.098 |
2 | 264150 | 0.097 |
4 | 681250 | 0.096 |
8 | 206526 | 0.095 |
3 | 226595 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 145683 | 2 |
0.100 | 345972 | 5 |
0.105 | 6836844 | 61 |
0.110 | 3402792 | 47 |
0.115 | 865254 | 21 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online